AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Stopped early · Phase 2
Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
In brief
RATIONALE: AMG 706 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well AMG 706 works in treating patients with persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer.
Key facts
- Study ID
- NCT00574951
- Run by
- Gynecologic Oncology Group
- People needed
- 23
- Starts
- 2007-12-01
- Last updated by the study team
- 2018-01-11
Who can join
Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Providence Saint Joseph Medical Center - Burbank — Burbank, California, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus — New Britain, Connecticut, United States
- University of Illinois Cancer Center — Chicago, Illinois, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates — Hinsdale, Illinois, United States
- St. Vincent Indianapolis Hospital — Indianapolis, Indiana, United States
- St. John's Regional Health Center — Springfield, Missouri, United States
- Hulston Cancer Center at Cox Medical Center South — Springfield, Missouri, United States
- Cancer Institute of New Jersey at Cooper - Voorhees — Voorhees Township, New Jersey, United States
- Blumenthal Cancer Center at Carolinas Medical Center — Charlotte, North Carolina, United States
- Case Comprehensive Cancer Center — Cleveland, Ohio, United States
- Mount Carmel Health - West Hospital — Columbus, Ohio, United States
- Lake/University Ireland Cancer Center — Mentor, Ohio, United States
- Oklahoma University Cancer Institute — Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital — Abington, Pennsylvania, United States
- Fox Chase Cancer Center - Philadelphia — Philadelphia, Pennsylvania, United States
- McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center — Reading, Pennsylvania, United States
- Harrington Cancer Center — Amarillo, Texas, United States
- University of Virginia Cancer Center — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.